Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.150
-0.020 (-1.71%)
Jul 20, 2026, 9:30 AM EDT - Market open
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.06 million as of July 20, 2026. Its market cap has decreased by -55.03% in one year.
Market Cap
2.06M
Enterprise Value
-2.43M
1-Year Change
-55.03%
Ranking
Category
Stock Price
$1.15
ChartMarket Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.06M, a decrease of -98.67%. That is a compound annual growth rate of -34.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 2.06M | -20.69% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clearmind Medicine | 2.90M |
| Onconetix | 2.81M |
| GRI Bio | 2.66M |
| Oragenics | 2.50M |
| Calidi Biotherapeutics | 2.34M |
| Azitra | 2.32M |
| Matinas BioPharma Holdings | 2.13M |
| VivoSim Labs | 2.06M |